image
Healthcare - Medical - Diagnostics & Research - NASDAQ - US
$ 310.63
-7.23 %
$ 9.65 B
Market Cap
27.2
P/E
1. INTRINSIC VALUE

Medpace Holdings, Inc. provides clinical research-based drug and medical device development services in North America, Europe, and Asia. It offers a suite of services supporting the clinical development process from Phase I to Phase IV in various therapeutic areas. The company also provides clinical development services to the pharmaceutical, biotechnology, and medical device industries; and development plan design, coordinated central laboratory, project management, regulatory affairs, clinical monitoring, data management and analysis, pharmacovigilance new drug application submissions, and post-marketing clinical support services. In addition, it offers bio-analytical laboratory services, clinical human pharmacology, imaging services, and electrocardiography reading support for clinical trials. The company was founded in 1992 and is based in Cincinnati, Ohio.[ Read More ]

The intrinsic value of one MEDP stock under the base case scenario is HIDDEN Compared to the current market price of 311 USD, Medpace Holdings, Inc. is HIDDEN

2. FUNDAMENTAL ANALYSIS

Price Chart MEDP

image
FINANCIALS
1.89 B REVENUE
29.17%
337 M OPERATING INCOME
20.86%
283 M NET INCOME
15.26%
433 M OPERATING CASH FLOW
11.68%
-34.6 M INVESTING CASH FLOW
10.62%
-183 M FINANCING CASH FLOW
76.46%
533 M REVENUE
0.99%
112 M OPERATING INCOME
6.77%
96.4 M NET INCOME
9.14%
149 M OPERATING CASH FLOW
28.07%
-10.5 M INVESTING CASH FLOW
18.01%
6.27 M FINANCING CASH FLOW
842.04%
Balance Sheet Decomposition Medpace Holdings, Inc.
image
Current Assets 594 M
Cash & Short-Term Investments 245 M
Receivables 298 M
Other Current Assets 50 M
Non-Current Assets 1.06 B
Long-Term Investments 0
PP&E 265 M
Other Non-Current Assets 798 M
Current Liabilities 925 M
Accounts Payable 31.9 M
Short-Term Debt 0
Other Current Liabilities 893 M
Non-Current Liabilities 173 M
Long-Term Debt 142 M
Other Non-Current Liabilities 30.6 M
EFFICIENCY
Earnings Waterfall Medpace Holdings, Inc.
image
Revenue 1.89 B
Cost Of Revenue 1.36 B
Gross Profit 525 M
Operating Expenses 188 M
Operating Income 337 M
Other Expenses 54 M
Net Income 283 M
RATIOS
27.81% GROSS MARGIN
27.81%
17.86% OPERATING MARGIN
17.86%
15.00% NET MARGIN
15.00%
50.60% ROE
50.60%
17.07% ROA
17.07%
50.77% ROIC
50.77%
FREE CASH FLOW ANALYSIS
Free Cash Flow Analysis Medpace Holdings, Inc.
image
Net Income 283 M
Depreciation & Amortization 26.3 M
Capital Expenditures -36.6 M
Stock-Based Compensation 20.5 M
Change in Working Capital 106 M
Others 110 M
Free Cash Flow 397 M
3. WALL STREET ANALYSTS ESTIMATES
Wall Street Analysts Price Targets Medpace Holdings, Inc.
image
Wall Street analysts predict an average 1-year price target for MEDP of $421 , with forecasts ranging from a low of $345 to a high of $469 .
MEDP Lowest Price Target Wall Street Target
345 USD 11.06%
MEDP Average Price Target Wall Street Target
421 USD 35.65%
MEDP Highest Price Target Wall Street Target
469 USD 50.98%
4. DIVIDEND ANALYSIS
0.00% DIVIDEND YIELD
0 USD DIVIDEND PER SHARE
5. COMPETITION
6. Ownership
Insider Ownership Medpace Holdings, Inc.
image
Sold
0-3 MONTHS
1.47 M USD 1
3-6 MONTHS
11.4 M USD 2
6-9 MONTHS
753 M USD 6
9-12 MONTHS
184 M USD 3
Bought
0 USD 0
0-3 MONTHS
0 USD 0
3-6 MONTHS
0 USD 0
6-9 MONTHS
0 USD 0
9-12 MONTHS
Date Value Insider Amount Avg Price
2 months ago
Aug 23, 2024
Sell 1.47 M USD
Kraft Robert O.
Director
- 3774
390.73 USD
5 months ago
Jun 05, 2024
Sell 3.08 M USD
BURWIG SUSAN E
Exec. VP, Operations
- 7681
401.2 USD
5 months ago
May 24, 2024
Sell 1.58 M USD
Troendle August J.
CEO
- 3987
395.22 USD
5 months ago
May 28, 2024
Sell 2.25 M USD
Troendle August J.
CEO
- 5695
395.49 USD
5 months ago
May 22, 2024
Sell 22 K USD
Troendle August J.
CEO
- 55
400 USD
5 months ago
May 20, 2024
Sell 1.61 M USD
Troendle August J.
CEO
- 4020
400.19 USD
6 months ago
May 15, 2024
Sell 13.1 M USD
Troendle August J.
CEO
- 32282
405.13 USD
6 months ago
May 16, 2024
Sell 2.85 M USD
Troendle August J.
CEO
- 7060
403.09 USD
6 months ago
May 10, 2024
Sell 2 M USD
Troendle August J.
CEO
- 4956
402.89 USD
6 months ago
May 08, 2024
Sell 1.92 M USD
Troendle August J.
CEO
- 4782
400.58 USD
6 months ago
May 09, 2024
Sell 1.39 M USD
Troendle August J.
CEO
- 3486
400.17 USD
6 months ago
May 06, 2024
Sell 9.79 M USD
Troendle August J.
CEO
- 24372
401.73 USD
6 months ago
May 07, 2024
Sell 11.3 M USD
Troendle August J.
CEO
- 28032
404.48 USD
6 months ago
May 01, 2024
Sell 5.19 M USD
Troendle August J.
CEO
- 12934
401.56 USD
6 months ago
May 02, 2024
Sell 1.36 M USD
Troendle August J.
CEO
- 3396
400.44 USD
6 months ago
Apr 29, 2024
Sell 6.05 M USD
Troendle August J.
CEO
- 15102
400.69 USD
6 months ago
Apr 30, 2024
Sell 732 K USD
Troendle August J.
CEO
- 1828
400.31 USD
8 months ago
Mar 15, 2024
Sell 41.1 K USD
BURWIG SUSAN E
Exec. VP, Operations
- 102
403 USD
8 months ago
Mar 14, 2024
Sell 102 K USD
Keating Ashley M.
Director
- 250
409.87 USD
8 months ago
Mar 06, 2024
Sell 41.3 M USD
Troendle August J.
CEO
- 100000
412.98 USD
8 months ago
Mar 07, 2024
Sell 30.8 M USD
Troendle August J.
CEO
- 75000
410.74 USD
8 months ago
Mar 08, 2024
Sell 10.2 M USD
Troendle August J.
CEO
- 25000
408.71 USD
8 months ago
Mar 06, 2024
Sell 41.3 M USD
Medpace Investors, LLC
10 percent owner
- 100000
412.98 USD
8 months ago
Mar 07, 2024
Sell 30.8 M USD
Medpace Investors, LLC
10 percent owner
- 75000
410.74 USD
8 months ago
Mar 08, 2024
Sell 10.2 M USD
Medpace Investors, LLC
10 percent owner
- 25000
408.71 USD
8 months ago
Mar 07, 2024
Sell 196 K USD
Keating Ashley M.
Director
- 472
415 USD
8 months ago
Mar 04, 2024
Sell 9 M USD
GEIGER JESSE J
President
- 22321
403.03 USD
8 months ago
Mar 04, 2024
Sell 20.2 M USD
Troendle August J.
CEO
- 50000
403.12 USD
8 months ago
Mar 05, 2024
Sell 20.1 M USD
Troendle August J.
CEO
- 50000
402.7 USD
8 months ago
Mar 04, 2024
Sell 20.2 M USD
Medpace Investors, LLC
10 percent owner
- 50000
403.12 USD
8 months ago
Mar 05, 2024
Sell 20.1 M USD
Medpace Investors, LLC
10 percent owner
- 50000
402.7 USD
8 months ago
Feb 29, 2024
Sell 7.87 M USD
Medpace Investors, LLC
10 percent owner
- 20000
393.71 USD
8 months ago
Mar 01, 2024
Sell 32.2 M USD
Medpace Investors, LLC
10 percent owner
- 80000
401.88 USD
8 months ago
Feb 29, 2024
Sell 7.87 M USD
Troendle August J.
CEO
- 20000
393.71 USD
8 months ago
Mar 01, 2024
Sell 32.2 M USD
Troendle August J.
CEO
- 80000
401.88 USD
8 months ago
Feb 29, 2024
Sell 458 K USD
EWALD STEPHEN P
General Counsel & Corp. Secy.
- 1163
393.505 USD
8 months ago
Mar 01, 2024
Sell 140 K USD
EWALD STEPHEN P
General Counsel & Corp. Secy.
- 350
400.79 USD
8 months ago
Feb 29, 2024
Sell 1.01 M USD
GEIGER JESSE J
President
- 2558
393.505 USD
8 months ago
Feb 28, 2024
Sell 202 K USD
Keating Ashley M.
Director
- 500
405 USD
8 months ago
Feb 27, 2024
Sell 20.1 M USD
Troendle August J.
CEO
- 50000
401.88 USD
8 months ago
Feb 28, 2024
Sell 20.2 M USD
Troendle August J.
CEO
- 50000
404.13 USD
8 months ago
Feb 27, 2024
Sell 20.1 M USD
Medpace Investors, LLC
10 percent owner
- 50000
401.88 USD
8 months ago
Feb 28, 2024
Sell 20.2 M USD
Medpace Investors, LLC
10 percent owner
- 50000
404.13 USD
8 months ago
Feb 23, 2024
Sell 40 M USD
Troendle August J.
CEO
- 100000
400.32 USD
8 months ago
Feb 26, 2024
Sell 22.9 M USD
Troendle August J.
CEO
- 56928
402.38 USD
8 months ago
Feb 23, 2024
Sell 40 M USD
Medpace Investors, LLC
10 percent owner
- 100000
400.32 USD
8 months ago
Feb 26, 2024
Sell 22.9 M USD
Medpace Investors, LLC
10 percent owner
- 56928
402.38 USD
8 months ago
Feb 21, 2024
Sell 13.8 M USD
Medpace Investors, LLC
10 percent owner
- 36012
383.44 USD
8 months ago
Feb 22, 2024
Sell 39.6 M USD
Medpace Investors, LLC
10 percent owner
- 100000
395.98 USD
8 months ago
Feb 21, 2024
Sell 13.8 M USD
Troendle August J.
CEO
- 36012
383.44 USD
8 months ago
Feb 22, 2024
Sell 39.6 M USD
Troendle August J.
CEO
- 100000
395.98 USD
9 months ago
Feb 16, 2024
Sell 19.6 M USD
Medpace Investors, LLC
10 percent owner
- 50000
391.75 USD
8 months ago
Feb 20, 2024
Sell 5.4 M USD
Medpace Investors, LLC
10 percent owner
- 13988
386.39 USD
9 months ago
Feb 16, 2024
Sell 19.6 M USD
Troendle August J.
CEO
- 50000
391.75 USD
8 months ago
Feb 20, 2024
Sell 5.4 M USD
Troendle August J.
CEO
- 13988
386.39 USD
11 months ago
Dec 14, 2023
Sell 3.16 M USD
BURWIG SUSAN E
Exec. VP, Operations
- 10391
304.15 USD
11 months ago
Dec 15, 2023
Sell 609 K USD
BURWIG SUSAN E
Exec. VP, Operations
- 2009
303 USD
11 months ago
Nov 29, 2023
Sell 864 K USD
Troendle August J.
CEO
- 3167
272.87 USD
11 months ago
Nov 29, 2023
Sell 4.93 M USD
Troendle August J.
CEO
- 18090
272.62 USD
11 months ago
Nov 30, 2023
Sell 2.14 M USD
Troendle August J.
CEO
- 7871
272.18 USD
11 months ago
Dec 01, 2023
Sell 6.57 M USD
Troendle August J.
CEO
- 24039
273.26 USD
11 months ago
Nov 29, 2023
Sell 864 K USD
Medpace Investors, LLC
10 percent owner
- 3167
272.87 USD
11 months ago
Nov 29, 2023
Sell 4.93 M USD
Medpace Investors, LLC
10 percent owner
- 18090
272.62 USD
11 months ago
Nov 30, 2023
Sell 2.14 M USD
Medpace Investors, LLC
10 percent owner
- 7871
272.18 USD
11 months ago
Dec 01, 2023
Sell 6.57 M USD
Medpace Investors, LLC
10 percent owner
- 24039
273.26 USD
11 months ago
Nov 27, 2023
Sell 6.9 M USD
Medpace Investors, LLC
10 percent owner
- 25000
276.1 USD
11 months ago
Nov 28, 2023
Sell 5.97 M USD
Medpace Investors, LLC
10 percent owner
- 21833
273.66 USD
11 months ago
Nov 27, 2023
Sell 6.9 M USD
Troendle August J.
CEO
- 25000
276.1 USD
11 months ago
Nov 28, 2023
Sell 5.97 M USD
Troendle August J.
CEO
- 21833
273.66 USD
11 months ago
Nov 22, 2023
Sell 6.95 M USD
Troendle August J.
CEO
- 25000
277.81 USD
11 months ago
Nov 22, 2023
Sell 6.95 M USD
Medpace Investors, LLC
10 percent owner
- 25000
277.81 USD
11 months ago
Nov 21, 2023
Sell 6.93 M USD
Medpace Investors, LLC
10 percent owner
- 25000
277.37 USD
11 months ago
Nov 21, 2023
Sell 6.93 M USD
Troendle August J.
CEO
- 25000
277.37 USD
1 year ago
Nov 17, 2023
Sell 13.7 M USD
Medpace Investors, LLC
10 percent owner
- 50000
273.91 USD
11 months ago
Nov 20, 2023
Sell 13.8 M USD
Medpace Investors, LLC
10 percent owner
- 50000
275.45 USD
1 year ago
Nov 17, 2023
Sell 13.7 M USD
Troendle August J.
CEO
- 50000
273.91 USD
11 months ago
Nov 20, 2023
Sell 13.8 M USD
Troendle August J.
CEO
- 50000
275.45 USD
1 year ago
Nov 14, 2023
Sell 7.08 M USD
Troendle August J.
CEO
- 25000
283.11 USD
1 year ago
Nov 15, 2023
Sell 9.35 M USD
Troendle August J.
CEO
- 33000
283.42 USD
1 year ago
Nov 16, 2023
Sell 4.79 M USD
Troendle August J.
CEO
- 17000
281.61 USD
1 year ago
Nov 14, 2023
Sell 7.08 M USD
Medpace Investors, LLC
10 percent owner
- 25000
283.11 USD
1 year ago
Nov 15, 2023
Sell 9.35 M USD
Medpace Investors, LLC
10 percent owner
- 33000
283.42 USD
1 year ago
Nov 16, 2023
Sell 4.79 M USD
Medpace Investors, LLC
10 percent owner
- 17000
281.61 USD
1 year ago
Sep 20, 2023
Sell 16.8 M USD
Troendle August J.
CEO
- 65653
255.48 USD
1 year ago
Sep 21, 2023
Sell 15.1 M USD
Troendle August J.
CEO
- 61655
244.27 USD
1 year ago
Sep 20, 2023
Sell 16.8 M USD
Medpace Investors, LLC
10 percent owner
- 65653
255.48 USD
1 year ago
Sep 21, 2023
Sell 15.1 M USD
Medpace Investors, LLC
10 percent owner
- 61655
244.27 USD
1 year ago
Sep 18, 2023
Sell 14.7 M USD
Medpace Investors, LLC
10 percent owner
- 53385
274.76 USD
1 year ago
Sep 19, 2023
Sell 35.7 M USD
Medpace Investors, LLC
10 percent owner
- 137379
259.66 USD
1 year ago
Sep 18, 2023
Sell 14.7 M USD
Troendle August J.
CEO
- 53385
274.76 USD
1 year ago
Sep 19, 2023
Sell 35.7 M USD
Troendle August J.
CEO
- 137379
259.66 USD
1 year ago
Aug 14, 2023
Sell 3.66 M USD
Kraft Robert O.
Director
- 13782
265.67 USD
1 year ago
Jul 31, 2023
Sell 1.78 M USD
Brady Kevin M.
CFO & Treasurer
- 7000
255 USD
1 year ago
Jul 27, 2023
Sell 5.56 M USD
EWALD STEPHEN P
General Counsel & Corp. Secy.
- 21850
254.39 USD
1 year ago
Jun 08, 2023
Sell 10.9 M USD
Troendle August J.
CEO
- 49347
220.85 USD
1 year ago
Jun 08, 2023
Sell 10.9 M USD
Medpace Investors, LLC
10 percent owner
- 49347
220.85 USD
1 year ago
Jun 06, 2023
Sell 12.9 M USD
Troendle August J.
CEO
- 58681
220.46 USD
1 year ago
Jun 07, 2023
Sell 24.6 M USD
Troendle August J.
CEO
- 110324
223.05 USD
1 year ago
Jun 06, 2023
Sell 12.9 M USD
Medpace Investors, LLC
10 percent owner
- 58681
220.46 USD
1 year ago
Jun 07, 2023
Sell 24.6 M USD
Medpace Investors, LLC
10 percent owner
- 110324
223.05 USD
1 year ago
Apr 25, 2023
Sell 7.02 M USD
Troendle August J.
CEO
- 31648
221.83 USD
1 year ago
Apr 25, 2023
Sell 7.02 M USD
Medpace Investors, LLC
10 percent owner
- 31648
221.83 USD
2 years ago
Nov 15, 2022
Sell 380 K USD
Brady Kevin M.
CFO & Treasurer
- 1656
229.3 USD
2 years ago
Nov 16, 2022
Sell 78.1 K USD
Brady Kevin M.
CFO & Treasurer
- 344
227.09 USD
2 years ago
Nov 15, 2022
Sell 1.61 M USD
GEIGER JESSE J
President
- 7000
230 USD
2 years ago
Nov 01, 2022
Sell 2.13 M USD
Kraft Robert O.
Director
- 9630
221.42 USD
2 years ago
Oct 27, 2022
Sell 1.43 M USD
EWALD STEPHEN P
General Counsel & Corp. Secy.
- 6500
220.53 USD
2 years ago
Sep 22, 2022
Bought 8.88 M USD
Medpace Investors, LLC
10 percent owner
+ 57426
154.59 USD
2 years ago
Sep 22, 2022
Bought 8.88 M USD
Troendle August J.
CEO
+ 57426
154.59 USD
2 years ago
Sep 21, 2022
Bought 15.2 M USD
Troendle August J.
CEO
+ 94119
161.63 USD
2 years ago
Sep 20, 2022
Bought 14.6 M USD
Troendle August J.
CEO
+ 94119
155.14 USD
2 years ago
Sep 21, 2022
Bought 15.2 M USD
Medpace Investors, LLC
10 percent owner
+ 94119
161.63 USD
2 years ago
Sep 20, 2022
Bought 14.6 M USD
Medpace Investors, LLC
10 percent owner
+ 94119
155.14 USD
2 years ago
Sep 19, 2022
Bought 14.4 M USD
Medpace Investors, LLC
10 percent owner
+ 94119
153.48 USD
2 years ago
Sep 16, 2022
Bought 9.35 M USD
Medpace Investors, LLC
10 percent owner
+ 62516
149.58 USD
2 years ago
Sep 19, 2022
Bought 14.4 M USD
Troendle August J.
CEO
+ 94119
153.48 USD
2 years ago
Sep 16, 2022
Bought 9.35 M USD
Troendle August J.
CEO
+ 62516
149.58 USD
2 years ago
Sep 15, 2022
Bought 9.57 M USD
Troendle August J.
CEO
+ 62516
153.11 USD
2 years ago
Sep 14, 2022
Bought 9.54 M USD
Troendle August J.
CEO
+ 62516
152.66 USD
2 years ago
Sep 15, 2022
Bought 9.57 M USD
Medpace Investors, LLC
10 percent owner
+ 62516
153.11 USD
2 years ago
Sep 14, 2022
Bought 9.54 M USD
Medpace Investors, LLC
10 percent owner
+ 62516
152.66 USD
2 years ago
Sep 13, 2022
Bought 9.82 M USD
Troendle August J.
CEO
+ 62516
157.12 USD
2 years ago
Sep 12, 2022
Bought 10.5 M USD
Troendle August J.
CEO
+ 62515
167.58 USD
2 years ago
Sep 13, 2022
Bought 9.82 M USD
Medpace Investors, LLC
10 percent owner
+ 62516
157.12 USD
2 years ago
Sep 12, 2022
Bought 10.5 M USD
Medpace Investors, LLC
10 percent owner
+ 62515
167.58 USD
2 years ago
Sep 08, 2022
Bought 9.29 M USD
Troendle August J.
CEO
+ 56557
164.33 USD
2 years ago
Sep 08, 2022
Bought 8.92 M USD
Troendle August J.
CEO
+ 56557
157.65 USD
2 years ago
Sep 09, 2022
Bought 9.29 M USD
Medpace Investors, LLC
10 percent owner
+ 56557
164.33 USD
2 years ago
Sep 08, 2022
Bought 8.92 M USD
Medpace Investors, LLC
director:
+ 56557
157.65 USD
2 years ago
Sep 06, 2022
Bought 8.52 M USD
Medpace Investors, LLC
director:
+ 56557
150.72 USD
2 years ago
Sep 06, 2022
Bought 8.35 M USD
Medpace Investors, LLC
10 percent owner
+ 56557
147.59 USD
2 years ago
Sep 06, 2022
Bought 8.52 M USD
Troendle August J.
CEO
+ 56557
150.72 USD
2 years ago
Sep 06, 2022
Bought 8.35 M USD
Troendle August J.
CEO
+ 56557
147.59 USD
2 years ago
Sep 02, 2022
Bought 7.06 M USD
Medpace Investors, LLC
10 percent owner
+ 48714
144.98 USD
2 years ago
Sep 01, 2022
Bought 6.08 M USD
Medpace Investors, LLC
director:
+ 42076
144.52 USD
2 years ago
Sep 02, 2022
Bought 7.06 M USD
Troendle August J.
CEO
+ 48714
144.98 USD
2 years ago
Sep 01, 2022
Bought 6.08 M USD
Troendle August J.
CEO
+ 42076
144.52 USD
2 years ago
Jul 18, 2022
Bought 1.21 M USD
Troendle August J.
CEO
+ 8330
145 USD
2 years ago
Jul 18, 2022
Bought 1.21 M USD
Medpace Investors, LLC
director:
+ 8330
145 USD
2 years ago
Jul 14, 2022
Bought 3.22 M USD
Troendle August J.
CEO
+ 22290
144.59 USD
2 years ago
Jul 14, 2022
Bought 3.22 M USD
Medpace Investors, LLC
director:
+ 22290
144.59 USD
2 years ago
Feb 17, 2022
Bought 72.9 K USD
DAVENPORT FRED B JR
Director
+ 500
145.8 USD
2 years ago
Jan 04, 2022
Sell 712 K USD
Troendle August J.
CEO
- 3338
213.44 USD
2 years ago
Jan 04, 2022
Sell 712 K USD
Medpace Investors, LLC
10 percent owner
- 3338
213.44 USD
2 years ago
Dec 30, 2021
Sell 3.83 M USD
Troendle August J.
CEO
- 17376
220.34 USD
2 years ago
Dec 31, 2021
Sell 2.86 M USD
Troendle August J.
CEO
- 13069
219.14 USD
2 years ago
Jan 03, 2022
Sell 4.2 M USD
Troendle August J.
CEO
- 19744
212.7 USD
2 years ago
Dec 30, 2021
Sell 3.83 M USD
Medpace Investors, LLC
10 percent owner
- 17376
220.34 USD
2 years ago
Dec 31, 2021
Sell 2.86 M USD
Medpace Investors, LLC
10 percent owner
- 13069
219.14 USD
2 years ago
Jan 03, 2022
Sell 4.2 M USD
Medpace Investors, LLC
10 percent owner
- 19744
212.7 USD
2 years ago
Dec 28, 2021
Sell 5.36 M USD
Troendle August J.
CEO
- 24118
222.18 USD
2 years ago
Dec 29, 2021
Sell 3.69 M USD
Troendle August J.
CEO
- 16750
220.16 USD
2 years ago
Dec 28, 2021
Sell 5.36 M USD
Medpace Investors, LLC
10 percent owner
- 24118
222.18 USD
2 years ago
Dec 29, 2021
Sell 3.69 M USD
Medpace Investors, LLC
10 percent owner
- 16750
220.16 USD
2 years ago
Dec 23, 2021
Sell 5.1 M USD
Troendle August J.
CEO
- 22830
223.19 USD
2 years ago
Dec 27, 2021
Sell 8.86 M USD
Troendle August J.
CEO
- 39171
226.11 USD
2 years ago
Dec 23, 2021
Sell 5.1 M USD
Medpace Investors, LLC
10 percent owner
- 22830
223.19 USD
2 years ago
Dec 27, 2021
Sell 8.86 M USD
Medpace Investors, LLC
10 percent owner
- 39171
226.11 USD
2 years ago
Dec 21, 2021
Sell 3.9 M USD
Troendle August J.
CEO
- 18133
215.17 USD
2 years ago
Dec 22, 2021
Sell 8.59 M USD
Troendle August J.
CEO
- 38960
220.5 USD
2 years ago
Dec 21, 2021
Sell 3.9 M USD
Medpace Investors, LLC
10 percent owner
- 18133
215.17 USD
2 years ago
Dec 22, 2021
Sell 8.59 M USD
Medpace Investors, LLC
10 percent owner
- 38960
220.5 USD
2 years ago
Dec 17, 2021
Sell 6.54 M USD
Troendle August J.
CEO
- 30605
213.59 USD
2 years ago
Dec 20, 2021
Sell 4.83 M USD
Troendle August J.
CEO
- 22734
212.57 USD
2 years ago
Dec 17, 2021
Sell 6.54 M USD
Medpace Investors, LLC
10 percent owner
- 30605
213.59 USD
2 years ago
Dec 20, 2021
Sell 4.83 M USD
Medpace Investors, LLC
10 percent owner
- 22734
212.57 USD
2 years ago
Dec 15, 2021
Sell 510 K USD
Troendle August J.
CEO
- 2424
210.28 USD
2 years ago
Dec 16, 2021
Sell 1.25 M USD
Troendle August J.
CEO
- 5959
210.22 USD
2 years ago
Dec 15, 2021
Sell 510 K USD
Medpace Investors, LLC
10 percent owner
- 2424
210.28 USD
2 years ago
Dec 16, 2021
Sell 1.25 M USD
Medpace Investors, LLC
10 percent owner
- 5959
210.22 USD
2 years ago
Dec 09, 2021
Sell 3.18 M USD
Troendle August J.
CEO
- 14994
212.13 USD
2 years ago
Dec 10, 2021
Sell 65 K USD
Troendle August J.
CEO
- 309
210.2 USD
2 years ago
Dec 09, 2021
Sell 3.18 M USD
Medpace Investors, LLC
10 percent owner
- 14994
212.13 USD
2 years ago
Dec 10, 2021
Sell 65 K USD
Medpace Investors, LLC
10 percent owner
- 309
210.2 USD
2 years ago
Dec 07, 2021
Sell 3.92 M USD
Troendle August J.
CEO
- 18520
211.78 USD
2 years ago
Dec 08, 2021
Sell 3.38 M USD
Troendle August J.
CEO
- 15871
212.89 USD
2 years ago
Dec 07, 2021
Sell 3.92 M USD
Medpace Investors, LLC
10 percent owner
- 18520
211.78 USD
2 years ago
Dec 08, 2021
Sell 3.38 M USD
Medpace Investors, LLC
10 percent owner
- 15871
212.89 USD
2 years ago
Dec 03, 2021
Sell 84.6 K USD
Medpace Investors, LLC
10 percent owner
- 400
211.48 USD
2 years ago
Dec 03, 2021
Sell 84.6 K USD
Troendle August J.
CEO
- 400
211.48 USD
2 years ago
Dec 01, 2021
Sell 5.64 M USD
Troendle August J.
CEO
- 26642
211.57 USD
2 years ago
Dec 02, 2021
Sell 1.28 M USD
Troendle August J.
CEO
- 6090
210.79 USD
2 years ago
Dec 01, 2021
Sell 5.64 M USD
Medpace Investors, LLC
10 percent owner
- 26642
211.57 USD
2 years ago
Dec 02, 2021
Sell 1.28 M USD
Medpace Investors, LLC
10 percent owner
- 6090
210.79 USD
2 years ago
Nov 29, 2021
Sell 2.57 M USD
Troendle August J.
CEO
- 12115
212.1 USD
2 years ago
Nov 30, 2021
Sell 41.4 K USD
Troendle August J.
CEO
- 197
210.29 USD
2 years ago
Nov 29, 2021
Sell 2.57 M USD
Medpace Investors, LLC
10 percent owner
- 12115
212.1 USD
2 years ago
Nov 30, 2021
Sell 41.4 K USD
Medpace Investors, LLC
10 percent owner
- 197
210.29 USD
2 years ago
Nov 24, 2021
Sell 3.11 M USD
Troendle August J.
CEO
- 14578
213.26 USD
2 years ago
Nov 26, 2021
Sell 3.18 M USD
Troendle August J.
CEO
- 15071
210.99 USD
2 years ago
Nov 24, 2021
Sell 3.11 M USD
Medpace Investors, LLC
10 percent owner
- 14578
213.26 USD
2 years ago
Nov 26, 2021
Sell 3.18 M USD
Medpace Investors, LLC
10 percent owner
- 15071
210.99 USD
2 years ago
Nov 22, 2021
Sell 10.8 M USD
Troendle August J.
CEO
- 48128
224.33 USD
2 years ago
Nov 23, 2021
Sell 5.54 M USD
Troendle August J.
CEO
- 26057
212.64 USD
2 years ago
Nov 22, 2021
Sell 10.8 M USD
Medpace Investors, LLC
10 percent owner
- 48128
224.33 USD
2 years ago
Nov 23, 2021
Sell 5.54 M USD
Medpace Investors, LLC
10 percent owner
- 26057
212.64 USD
3 years ago
Nov 03, 2021
Sell 39.9 K USD
King Tom C
Director
- 176
226.63 USD
3 years ago
Nov 02, 2021
Sell 283 K USD
Brady Kevin M.
CFO & Treasurer
- 1250
226.5 USD
3 years ago
Oct 26, 2021
Sell 2.09 M USD
EWALD STEPHEN P
General Counsel & Corp. Secy.
- 10000
209.13 USD
3 years ago
Oct 26, 2021
Sell 2.11 M USD
GEIGER JESSE J
President
- 10000
211.36 USD
3 years ago
Oct 26, 2021
Sell 420 K USD
Keating Ashley M.
Director
- 2000
210 USD
3 years ago
Sep 03, 2021
Sell 390 K USD
Keating Ashley M.
Director
- 2000
195 USD
3 years ago
Sep 02, 2021
Sell 10.6 M USD
BURWIG SUSAN E
Exec. VP, Operations
- 55037
192.16 USD
3 years ago
Sep 03, 2021
Sell 1.38 M USD
BURWIG SUSAN E
Exec. VP, Operations
- 7185
192.67 USD
3 years ago
Sep 02, 2021
Sell 5.8 M USD
Medpace Investors, LLC
10 percent owner
- 30234
191.85 USD
3 years ago
Sep 03, 2021
Sell 116 K USD
Medpace Investors, LLC
10 percent owner
- 604
191.82 USD
3 years ago
Sep 02, 2021
Sell 5.8 M USD
Troendle August J.
CEO
- 30234
191.85 USD
3 years ago
Sep 03, 2021
Sell 116 K USD
Troendle August J.
CEO
- 604
191.82 USD
3 years ago
Aug 31, 2021
Sell 2.31 M USD
Troendle August J.
CEO
- 12675
182.04 USD
3 years ago
Sep 01, 2021
Sell 2.66 M USD
Troendle August J.
CEO
- 14304
186.29 USD
3 years ago
Aug 31, 2021
Sell 2.31 M USD
Medpace Investors, LLC
10 percent owner
- 12675
182.04 USD
3 years ago
Sep 01, 2021
Sell 2.66 M USD
Medpace Investors, LLC
10 percent owner
- 14304
186.29 USD
3 years ago
Aug 27, 2021
Sell 2.15 M USD
Troendle August J.
CEO
- 11840
181.83 USD
3 years ago
Aug 30, 2021
Sell 2.24 M USD
Troendle August J.
CEO
- 12236
183.14 USD
3 years ago
Aug 27, 2021
Sell 2.15 M USD
Medpace Investors, LLC
10 percent owner
- 11840
181.83 USD
3 years ago
Aug 30, 2021
Sell 2.24 M USD
Medpace Investors, LLC
10 percent owner
- 12236
183.14 USD
3 years ago
Aug 25, 2021
Sell 1.38 M USD
Medpace Investors, LLC
10 percent owner
- 7622
180.54 USD
3 years ago
Aug 26, 2021
Sell 84 K USD
Medpace Investors, LLC
10 percent owner
- 466
180.17 USD
3 years ago
Aug 25, 2021
Sell 1.38 M USD
Troendle August J.
CEO
- 7622
180.54 USD
3 years ago
Aug 26, 2021
Sell 84 K USD
Troendle August J.
CEO
- 466
180.17 USD
3 years ago
Aug 23, 2021
Sell 267 K USD
Medpace Investors, LLC
10 percent owner
- 1482
180.22 USD
3 years ago
Aug 24, 2021
Sell 327 K USD
Medpace Investors, LLC
10 percent owner
- 1814
180.06 USD
3 years ago
Aug 23, 2021
Sell 267 K USD
Troendle August J.
CEO
- 1482
180.22 USD
3 years ago
Aug 24, 2021
Sell 327 K USD
Troendle August J.
CEO
- 1814
180.06 USD
3 years ago
Aug 18, 2021
Sell 415 K USD
Troendle August J.
CEO
- 2301
180.49 USD
3 years ago
Aug 18, 2021
Sell 415 K USD
Medpace Investors, LLC
10 percent owner
- 2301
180.49 USD
3 years ago
Aug 16, 2021
Sell 3.07 M USD
Medpace Investors, LLC
10 percent owner
- 16817
182.83 USD
3 years ago
Aug 17, 2021
Sell 955 K USD
Medpace Investors, LLC
10 percent owner
- 5246
182.1 USD
3 years ago
Aug 16, 2021
Sell 3.07 M USD
Troendle August J.
CEO
- 16817
182.83 USD
3 years ago
Aug 17, 2021
Sell 955 K USD
Troendle August J.
CEO
- 5246
182.1 USD
3 years ago
Aug 05, 2021
Sell 100 K USD
Troendle August J.
CEO
- 556
180.04 USD
3 years ago
Aug 05, 2021
Sell 100 K USD
Medpace Investors, LLC
10 percent owner
- 556
180.04 USD
3 years ago
Aug 04, 2021
Sell 178 K USD
Keating Ashley M.
Director
- 1000
178 USD
3 years ago
Jul 29, 2021
Sell 39.7 K USD
King Tom C
Director
- 226
175.74 USD
3 years ago
Jul 26, 2021
Sell 2.76 M USD
Troendle August J.
President & CEO
- 15209
181.47 USD
3 years ago
Jul 27, 2021
Sell 23.7 K USD
Troendle August J.
President & CEO
- 131
180.93 USD
3 years ago
Jul 26, 2021
Sell 2.76 M USD
Medpace Investors, LLC
10 percent owner
- 15209
181.47 USD
3 years ago
Jul 27, 2021
Sell 23.7 K USD
Medpace Investors, LLC
10 percent owner
- 131
180.93 USD
3 years ago
Jul 22, 2021
Sell 1.54 M USD
Troendle August J.
President & CEO
- 8516
180.63 USD
3 years ago
Jul 23, 2021
Sell 3.42 M USD
Troendle August J.
President & CEO
- 18882
181.21 USD
3 years ago
Jul 22, 2021
Sell 1.54 M USD
Medpace Investors, LLC
10 percent owner
- 8516
180.63 USD
3 years ago
Jul 23, 2021
Sell 3.42 M USD
Medpace Investors, LLC
10 percent owner
- 18882
181.21 USD
3 years ago
Jul 20, 2021
Sell 1.86 M USD
Troendle August J.
President & CEO
- 10176
183.06 USD
3 years ago
Jul 21, 2021
Sell 1.68 M USD
Troendle August J.
President & CEO
- 9206
182.42 USD
3 years ago
Jul 20, 2021
Sell 1.86 M USD
Medpace Investors, LLC
10 percent owner
- 10176
183.06 USD
3 years ago
Jul 21, 2021
Sell 1.68 M USD
Medpace Investors, LLC
10 percent owner
- 9206
182.42 USD
3 years ago
Jul 16, 2021
Sell 2.28 M USD
Troendle August J.
President & CEO
- 12454
182.83 USD
3 years ago
Jul 19, 2021
Sell 261 K USD
Troendle August J.
President & CEO
- 1442
181.11 USD
3 years ago
Jul 16, 2021
Sell 2.28 M USD
Medpace Investors, LLC
10 percent owner
- 12454
182.83 USD
3 years ago
Jul 19, 2021
Sell 261 K USD
Medpace Investors, LLC
10 percent owner
- 1442
181.11 USD
3 years ago
Jul 14, 2021
Sell 2.01 M USD
Medpace Investors, LLC
10 percent owner
- 11026
182.63 USD
3 years ago
Jul 15, 2021
Sell 2.49 M USD
Medpace Investors, LLC
10 percent owner
- 13697
181.88 USD
3 years ago
Jul 14, 2021
Sell 2.01 M USD
Troendle August J.
President & CEO
- 11026
182.63 USD
3 years ago
Jul 15, 2021
Sell 2.49 M USD
Troendle August J.
President & CEO
- 13697
181.88 USD
3 years ago
Jul 12, 2021
Sell 1.93 M USD
Medpace Investors, LLC
10 percent owner
- 10540
183.22 USD
3 years ago
Jul 13, 2021
Sell 2.39 M USD
Medpace Investors, LLC
10 percent owner
- 13050
182.96 USD
3 years ago
Jul 12, 2021
Sell 1.93 M USD
Troendle August J.
President & CEO
- 10540
183.22 USD
3 years ago
Jul 13, 2021
Sell 2.39 M USD
Troendle August J.
President & CEO
- 13050
182.96 USD
3 years ago
Jul 08, 2021
Sell 712 K USD
Troendle August J.
President & CEO
- 3951
180.18 USD
3 years ago
Jul 09, 2021
Sell 2.31 M USD
Troendle August J.
President & CEO
- 12597
183.34 USD
3 years ago
Jul 08, 2021
Sell 712 K USD
Medpace Investors, LLC
10 percent owner
- 3951
180.18 USD
3 years ago
Jul 09, 2021
Sell 2.31 M USD
Medpace Investors, LLC
10 percent owner
- 12597
183.34 USD
3 years ago
Jul 06, 2021
Sell 854 K USD
Medpace Investors, LLC
10 percent owner
- 4729
180.58 USD
3 years ago
Jul 07, 2021
Sell 825 K USD
Medpace Investors, LLC
10 percent owner
- 4574
180.33 USD
3 years ago
Jul 06, 2021
Sell 854 K USD
Troendle August J.
President & CEO
- 4729
180.58 USD
3 years ago
Jul 07, 2021
Sell 825 K USD
Troendle August J.
President & CEO
- 4574
180.33 USD
3 years ago
Jul 01, 2021
Sell 42.8 K USD
Troendle August J.
President & CEO
- 238
180.03 USD
3 years ago
Jul 02, 2021
Sell 641 K USD
Troendle August J.
President & CEO
- 3556
180.16 USD
3 years ago
Jul 01, 2021
Sell 42.8 K USD
Medpace Investors, LLC
10 percent owner
- 238
180.03 USD
3 years ago
Jul 02, 2021
Sell 641 K USD
Medpace Investors, LLC
10 percent owner
- 3556
180.16 USD
3 years ago
Jun 29, 2021
Sell 892 K USD
Troendle August J.
President & CEO
- 4926
181.11 USD
3 years ago
Jun 29, 2021
Sell 892 K USD
Medpace Investors, LLC
10 percent owner
- 4926
181.11 USD
3 years ago
Jun 25, 2021
Sell 1.96 M USD
Medpace Investors, LLC
10 percent owner
- 10846
180.56 USD
3 years ago
Jun 28, 2021
Sell 1.49 M USD
Medpace Investors, LLC
10 percent owner
- 8225
181.15 USD
3 years ago
Jun 25, 2021
Sell 1.96 M USD
Troendle August J.
President & CEO
- 10846
180.56 USD
3 years ago
Jun 28, 2021
Sell 1.49 M USD
Troendle August J.
President & CEO
- 8225
181.15 USD
3 years ago
Jun 23, 2021
Sell 332 K USD
Medpace Investors, LLC
10 percent owner
- 1837
180.79 USD
3 years ago
Jun 23, 2021
Sell 332 K USD
Troendle August J.
President & CEO
- 1837
180.79 USD
3 years ago
Jun 21, 2021
Sell 1.7 M USD
Troendle August J.
President & CEO
- 9345
181.86 USD
3 years ago
Jun 22, 2021
Sell 2.21 M USD
Troendle August J.
President & CEO
- 12133
182.31 USD
3 years ago
Jun 21, 2021
Sell 1.7 M USD
Medpace Investors, LLC
10 percent owner
- 9345
181.86 USD
3 years ago
Jun 22, 2021
Sell 2.21 M USD
Medpace Investors, LLC
10 percent owner
- 12133
182.31 USD
3 years ago
Jun 17, 2021
Sell 1.62 M USD
Troendle August J.
President & CEO
- 8927
181.2 USD
3 years ago
Jun 18, 2021
Sell 228 K USD
Troendle August J.
President & CEO
- 1261
180.43 USD
3 years ago
Jun 17, 2021
Sell 1.62 M USD
Medpace Investors, LLC
10 percent owner
- 8927
181.2 USD
3 years ago
Jun 18, 2021
Sell 228 K USD
Medpace Investors, LLC
10 percent owner
- 1261
180.43 USD
3 years ago
Jun 15, 2021
Sell 2.86 M USD
Medpace Investors, LLC
10 percent owner
- 15706
182 USD
3 years ago
Jun 16, 2021
Sell 3.15 M USD
Medpace Investors, LLC
10 percent owner
- 17413
181.13 USD
3 years ago
Jun 15, 2021
Sell 2.86 M USD
Troendle August J.
President & CEO
- 15706
182 USD
3 years ago
Jun 16, 2021
Sell 3.15 M USD
Troendle August J.
President & CEO
- 17413
181.13 USD
3 years ago
Jun 14, 2021
Sell 1.32 M USD
BURWIG SUSAN E
Exec. VP, Operations
- 7400
179.016 USD
3 years ago
Jun 14, 2021
Sell 1.36 M USD
BURWIG SUSAN E
Exec. VP, Operations
- 7600
178.901 USD
3 years ago
Apr 23, 2021
Sell 1.49 M USD
Medpace Investors, LLC
10 percent owner
- 7805
190.51 USD
3 years ago
Apr 26, 2021
Sell 4.01 M USD
Medpace Investors, LLC
10 percent owner
- 20729
193.38 USD
3 years ago
Apr 23, 2021
Sell 1.49 M USD
Troendle August J.
President & CEO
- 7805
190.51 USD
3 years ago
Apr 26, 2021
Sell 4.01 M USD
Troendle August J.
President & CEO
- 20729
193.38 USD
3 years ago
Apr 21, 2021
Sell 2.93 M USD
Medpace Investors, LLC
10 percent owner
- 15687
187.02 USD
3 years ago
Apr 22, 2021
Sell 2.71 M USD
Medpace Investors, LLC
10 percent owner
- 14377
188.64 USD
3 years ago
Apr 21, 2021
Sell 2.93 M USD
Troendle August J.
President & CEO
- 15687
187.02 USD
3 years ago
Apr 22, 2021
Sell 2.71 M USD
Troendle August J.
President & CEO
- 14377
188.64 USD
3 years ago
Apr 19, 2021
Sell 1.53 M USD
Medpace Investors, LLC
10 percent owner
- 8471
180.9 USD
3 years ago
Apr 20, 2021
Sell 3.22 M USD
Medpace Investors, LLC
10 percent owner
- 17623
182.44 USD
3 years ago
Apr 19, 2021
Sell 1.53 M USD
Troendle August J.
President & CEO
- 8471
180.9 USD
3 years ago
Apr 20, 2021
Sell 3.22 M USD
Troendle August J.
President & CEO
- 17623
182.44 USD
3 years ago
Apr 14, 2021
Sell 671 K USD
Medpace Investors, LLC
10 percent owner
- 3720
180.48 USD
3 years ago
Apr 15, 2021
Sell 5.84 M USD
Medpace Investors, LLC
10 percent owner
- 31270
186.65 USD
3 years ago
Apr 16, 2021
Sell 3.16 M USD
Medpace Investors, LLC
10 percent owner
- 17528
180.3 USD
3 years ago
Apr 14, 2021
Sell 217 K USD
EWALD STEPHEN P
General Counsel & Corp. Secy.
- 1200
180.67 USD
3 years ago
Apr 15, 2021
Sell 704 K USD
EWALD STEPHEN P
General Counsel & Corp. Secy.
- 3800
185.18 USD
3 years ago
Apr 14, 2021
Sell 540 K USD
GEIGER JESSE J
CFO & COO, Lab Operations
- 3000
180 USD
3 years ago
Apr 14, 2021
Sell 671 K USD
Troendle August J.
President & CEO
- 3720
180.48 USD
3 years ago
Apr 15, 2021
Sell 5.84 M USD
Troendle August J.
President & CEO
- 31270
186.65 USD
3 years ago
Apr 16, 2021
Sell 3.16 M USD
Troendle August J.
President & CEO
- 17528
180.3 USD
3 years ago
Mar 03, 2021
Sell 1.04 M USD
BURWIG SUSAN E
Exec. VP, Operations
- 6211
167 USD
3 years ago
Feb 10, 2021
Sell 640 K USD
GEIGER JESSE J
CFO & COO, Lab Operations
- 4000
160 USD
3 years ago
Feb 09, 2021
Sell 1.55 M USD
EWALD STEPHEN P
General Counsel & Corp. Secy.
- 10000
155.48 USD
3 years ago
Jan 08, 2021
Sell 3.75 M USD
Medpace Investors, LLC
10 percent owner
- 26666
140.71 USD
3 years ago
Jan 08, 2021
Sell 3.75 M USD
Troendle August J.
President & CEO
- 26666
140.71 USD
3 years ago
Jan 06, 2021
Sell 12.8 M USD
Medpace Investors, LLC
10 percent owner
- 91667
140.06 USD
3 years ago
Jan 07, 2021
Sell 13.1 M USD
Medpace Investors, LLC
10 percent owner
- 93552
140.06 USD
3 years ago
Jan 06, 2021
Sell 12.8 M USD
Troendle August J.
President & CEO
- 91667
140.06 USD
3 years ago
Jan 07, 2021
Sell 13.1 M USD
Troendle August J.
President & CEO
- 93552
140.06 USD
3 years ago
Jan 04, 2021
Sell 1.42 M USD
Medpace Investors, LLC
10 percent owner
- 10127
140.01 USD
3 years ago
Jan 04, 2021
Sell 1.42 M USD
Troendle August J.
President & CEO
- 10127
140.01 USD
3 years ago
Dec 30, 2020
Sell 2.79 M USD
Troendle August J.
President & CEO
- 19930
140.01 USD
3 years ago
Dec 30, 2020
Sell 2.79 M USD
Medpace Investors, LLC
10 percent owner
- 19930
140.01 USD
3 years ago
Dec 23, 2020
Sell 497 K USD
Troendle August J.
President & CEO
- 3547
140.11 USD
3 years ago
Dec 24, 2020
Sell 536 K USD
Troendle August J.
President & CEO
- 3829
140 USD
3 years ago
Dec 28, 2020
Sell 192 K USD
Troendle August J.
President & CEO
- 1374
140 USD
3 years ago
Dec 23, 2020
Sell 497 K USD
Medpace Investors, LLC
10 percent owner
- 3547
140.11 USD
3 years ago
Dec 24, 2020
Sell 536 K USD
Medpace Investors, LLC
10 percent owner
- 3829
140 USD
3 years ago
Dec 28, 2020
Sell 192 K USD
Medpace Investors, LLC
10 percent owner
- 1374
140 USD
3 years ago
Dec 22, 2020
Sell 4.66 M USD
Troendle August J.
President & CEO
- 33260
140.01 USD
3 years ago
Dec 22, 2020
Sell 4.66 M USD
Medpace Investors, LLC
10 percent owner
- 33260
140.01 USD
3 years ago
Dec 18, 2020
Sell 30.6 M USD
Medpace Investors, LLC
10 percent owner
- 216048
141.85 USD
3 years ago
Dec 18, 2020
Sell 30.6 M USD
Troendle August J.
President & CEO
- 216048
141.85 USD
3 years ago
Dec 14, 2020
Sell 596 K USD
GEIGER JESSE J
CFO & COO, Lab Operations
- 4200
142 USD
3 years ago
Dec 10, 2020
Sell 1.4 M USD
EWALD STEPHEN P
General Counsel & Corp. Secy.
- 10000
140.07 USD
3 years ago
Dec 01, 2020
Sell 1.83 M USD
Medpace Investors, LLC
10 percent owner
- 14000
130.86 USD
3 years ago
Dec 01, 2020
Sell 1.83 M USD
Troendle August J.
President & CEO
- 14000
130.86 USD
4 years ago
Sep 01, 2020
Sell 404 K USD
GEIGER JESSE J
CFO & COO, Lab Operations
- 3110
130 USD
4 years ago
Aug 26, 2020
Sell 1.72 M USD
Medpace Investors, LLC
10 percent owner
- 13889
123.53 USD
4 years ago
Aug 27, 2020
Sell 248 K USD
Medpace Investors, LLC
10 percent owner
- 2034
121.94 USD
4 years ago
Aug 26, 2020
Sell 1.72 M USD
Troendle August J.
President & CEO
- 13889
123.53 USD
4 years ago
Aug 27, 2020
Sell 248 K USD
Troendle August J.
President & CEO
- 2034
121.94 USD
4 years ago
Aug 24, 2020
Sell 2.33 M USD
Troendle August J.
President & CEO
- 18903
123.36 USD
4 years ago
Aug 25, 2020
Sell 1.43 M USD
Troendle August J.
President & CEO
- 11597
123.23 USD
4 years ago
Aug 24, 2020
Sell 2.33 M USD
Medpace Investors, LLC
10 percent owner
- 18903
123.36 USD
4 years ago
Aug 25, 2020
Sell 1.43 M USD
Medpace Investors, LLC
10 percent owner
- 11597
123.23 USD
4 years ago
Aug 20, 2020
Sell 2.37 M USD
Troendle August J.
President & CEO
- 18813
125.83 USD
4 years ago
Aug 21, 2020
Sell 3.02 M USD
Troendle August J.
President & CEO
- 24304
124.37 USD
4 years ago
Aug 20, 2020
Sell 2.37 M USD
Medpace Investors, LLC
10 percent owner
- 18813
125.83 USD
4 years ago
Aug 21, 2020
Sell 3.02 M USD
Medpace Investors, LLC
10 percent owner
- 24304
124.37 USD
4 years ago
Aug 18, 2020
Sell 2.11 M USD
Medpace Investors, LLC
10 percent owner
- 16589
127.26 USD
4 years ago
Aug 19, 2020
Sell 2.76 M USD
Medpace Investors, LLC
10 percent owner
- 21614
127.63 USD
4 years ago
Aug 18, 2020
Sell 2.11 M USD
Troendle August J.
President & CEO
- 16589
127.26 USD
4 years ago
Aug 19, 2020
Sell 2.76 M USD
Troendle August J.
President & CEO
- 21614
127.63 USD
4 years ago
Aug 17, 2020
Sell 448 K USD
GEIGER JESSE J
CFO & COO, Lab Operations
- 3500
128 USD
4 years ago
Aug 14, 2020
Sell 2.14 M USD
Troendle August J.
President & CEO
- 16857
127.07 USD
4 years ago
Aug 17, 2020
Sell 2.11 M USD
Troendle August J.
President & CEO
- 16485
128.18 USD
4 years ago
Aug 14, 2020
Sell 2.14 M USD
Medpace Investors, LLC
10 percent owner
- 16857
127.07 USD
4 years ago
Aug 17, 2020
Sell 2.11 M USD
Medpace Investors, LLC
10 percent owner
- 16485
128.18 USD
4 years ago
Aug 12, 2020
Sell 2.79 M USD
Troendle August J.
President & CEO
- 21916
127.21 USD
4 years ago
Aug 13, 2020
Sell 2.13 M USD
Troendle August J.
President & CEO
- 16671
127.87 USD
4 years ago
Aug 12, 2020
Sell 2.79 M USD
Medpace Investors, LLC
10 percent owner
- 21916
127.21 USD
4 years ago
Aug 13, 2020
Sell 2.13 M USD
Medpace Investors, LLC
10 percent owner
- 16671
127.87 USD
4 years ago
Aug 10, 2020
Sell 5.82 M USD
Troendle August J.
President & CEO
- 48148
120.79 USD
4 years ago
Aug 11, 2020
Sell 4.84 M USD
Troendle August J.
President & CEO
- 38642
125.3 USD
4 years ago
Aug 10, 2020
Sell 5.82 M USD
Medpace Investors, LLC
10 percent owner
- 48148
120.79 USD
4 years ago
Aug 11, 2020
Sell 4.84 M USD
Medpace Investors, LLC
10 percent owner
- 38642
125.3 USD
4 years ago
Aug 10, 2020
Sell 900 K USD
EWALD STEPHEN P
General Counsel & Corp. Secy.
- 7400
121.57 USD
4 years ago
Aug 06, 2020
Sell 882 K USD
BURWIG SUSAN E
Exec. VP, Operations
- 7000
126 USD
4 years ago
Aug 06, 2020
Sell 1.84 M USD
Troendle August J.
President & CEO
- 15033
122.43 USD
4 years ago
Aug 07, 2020
Sell 2.47 M USD
Troendle August J.
President & CEO
- 19942
123.63 USD
7. News
Reminder of Investigation of MEDP: Kessler Topaz Meltzer & Check, LLP Encourages Medpace Holdings, Inc. (NASDAQ: MEDP) Investors with Significant Losses to Contact the Firm RADNOR, PA / ACCESSWIRE / November 15, 2024 / The law firm of Kessler Topaz Meltzer & Check, LLP(www.ktmc.com) is currently investigating potential violations of the federal securities laws on behalf of investors of Medpace Holdings, Inc. (NASDAQ:MEDP) ("Medpace"). On October 21, 2024, during after-market hours, Medpace reported its third quarter 2024 financial results and cut its revenue guidance for full-year 2024. accesswire.com - 1 day ago
Medpace Holdings, Inc. Is Being Investigated For Securities Fraud And Investors With Losses Are Invited To Join The Schall Law Firm LOS ANGELES, CA / ACCESSWIRE / November 15, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Medpace Holdings, Inc. ("Medpace" or "the Company") (NASDAQ:MEDP) for violations of the securities laws. The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors. accesswire.com - 1 day ago
MEDP Investigation Reminder: Kessler Topaz Meltzer & Check, LLP Encourages Medpace Holdings, Inc. (NASDAQ: MEDP) Investors with Significant Losses to Contact the Firm RADNOR, Pa. , Nov. 15, 2024 /PRNewswire/ -- The law firm of Kessler Topaz Meltzer & Check, LLP (www.ktmc.com) is currently investigating potential violations of the federal securities laws on behalf of investors of Medpace Holdings, Inc. (NASDAQ: MEDP) ("Medpace"). prnewswire.com - 1 day ago
Notice of Investigation of MEDP: Kessler Topaz Meltzer & Check, LLP Encourages Medpace Holdings, Inc. (NASDAQ: MEDP) Investors with Significant Losses to Contact the Firm RADNOR, PA / ACCESSWIRE / November 14, 2024 / The law firm of Kessler Topaz Meltzer & Check, LLP(www.ktmc.com) is currently investigating potential violations of the federal securities laws on behalf of investors of Medpace Holdings, Inc. (NASDAQ:MEDP) ("Medpace"). On October 21, 2024, during after-market hours, Medpace reported its third quarter 2024 financial results and cut its revenue guidance for full-year 2024. accesswire.com - 2 days ago
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Medpace Holdings, Inc. - MEDP NEW YORK, NY / ACCESSWIRE / November 14, 2024 / Pomerantz LLP is investigating claims on behalf of investors of Medpace Holdings, Inc. ("Medpace" or the "Company") (NASDAQ:MEDP). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. accesswire.com - 2 days ago
The Schall Law Firm Encourages Stockholder Participation In An Inquiry Into Medpace Holdings Inc's Securities Law Violations LOS ANGELES, CA / ACCESSWIRE / November 14, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Medpace Holdings, Inc. ("Medpace" or "the Company") (NASDAQ:MEDP) for violations of the securities laws. The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors. accesswire.com - 2 days ago
MEDP Investigation: Kessler Topaz Meltzer & Check, LLP Encourages Medpace Holdings, Inc. (NASDAQ:MEDP) Investors with Significant Losses to Contact the Firm RADNOR, PA / ACCESSWIRE / November 13, 2024 / The law firm of Kessler Topaz Meltzer & Check, LLP (www.ktmc.com) is currently investigating potential violations of the federal securities laws on behalf of investors of Medpace Holdings, Inc. (NASDAQ:MEDP) ("Medpace"). On October 21, 2024, during after-market hours, Medpace reported its third quarter 2024 financial results and cut its revenue guidance for full-year 2024. accesswire.com - 3 days ago
Medpace Holdings, Inc. Is Being Investigated For Possible Securities Fraud And Investors With Losses Are Urged To Contact The Schall Law Firm LOS ANGELES, CA / ACCESSWIRE / November 13, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Medpace Holdings, Inc. ("Medpace" or "the Company") (NASDAQ:MEDP) for violations of the securities laws. The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors. accesswire.com - 3 days ago
MEDPACE ALERT: Bragar Eagel & Squire, P.C. is Investigating Medpace Holdings, Inc. on Behalf of Medpace Stockholders and Encourages Investors to Contact the Firm NEW YORK, Nov. 12, 2024 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, is investigating potential claims against Medpace Holdings, Inc. (“Medpace” or the “Company”) (NASDAQ: MEDP) on behalf of Medpace stockholders. Our investigation concerns whether Medpace has violated the federal securities laws and/or engaged in other unlawful business practices. globenewswire.com - 4 days ago
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Medpace Holdings, Inc. - MEDP NEW YORK CITY, NY / ACCESSWIRE / November 12, 2024 / Pomerantz LLP is investigating claims on behalf of investors of Medpace Holdings, Inc. ("Medpace" or the "Company") (NASDAQ:MEDP). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. accesswire.com - 4 days ago
MEDP Investigation: Kessler Topaz Meltzer & Check, LLP Encourages Medpace Holdings, Inc. (NASDAQ: MEDP) Investors with Significant Losses to Contact the Firm RADNOR, Pa., Nov. 12, 2024 (GLOBE NEWSWIRE) -- The law firm of Kessler Topaz Meltzer & Check, LLP (www.ktmc.com) is currently investigating potential violations of the federal securities laws on behalf of investors of Medpace Holdings, Inc. (NASDAQ: MEDP) (“Medpace”). globenewswire.com - 4 days ago
The Schall Law Firm Invites Shareholders To Join An Inquiry Into Medpace Holdings Inc For Securities Law Violations LOS ANGELES, CA / ACCESSWIRE / November 12, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Medpace Holdings, Inc. ("Medpace" or "the Company") (NASDAQ:MEDP) for violations of the securities laws. The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors. accesswire.com - 4 days ago
8. Profile Summary

Medpace Holdings, Inc. MEDP

image
COUNTRY US
INDUSTRY Medical - Diagnostics & Research
MARKET CAP $ 9.65 B
Dividend Yield 0.00%
Description Medpace Holdings, Inc. provides clinical research-based drug and medical device development services in North America, Europe, and Asia. It offers a suite of services supporting the clinical development process from Phase I to Phase IV in various therapeutic areas. The company also provides clinical development services to the pharmaceutical, biotechnology, and medical device industries; and development plan design, coordinated central laboratory, project management, regulatory affairs, clinical monitoring, data management and analysis, pharmacovigilance new drug application submissions, and post-marketing clinical support services. In addition, it offers bio-analytical laboratory services, clinical human pharmacology, imaging services, and electrocardiography reading support for clinical trials. The company was founded in 1992 and is based in Cincinnati, Ohio.
Contact 5375 Medpace Way, Cincinnati, OH, 45227 https://www.medpace.com
IPO Date Aug. 11, 2016
Employees 5900
Officers Mr. Stephen P. Ewald J.D. Chief Compliance Officer, General Counsel & Corporate Secretary Ms. Lauren Morris Associate Director of Investors Relations Mr. Jesse J. Geiger BBA, CPA President Mr. Kevin M. Brady Chief Financial Officer & Treasurer Ms. Susan E. Burwig BSN, MA Executive Vice President of Operations Brandon Ebken Chief Information Officer Mr. Todd Meyers Vice President of Business Development & Marketing John T. Wynne MBA Senior Vice President of Commercial Operations & Clinical Pharmacology Unit Mr. Reinilde Heyrman M.D. Chief Medical Officer of Medical Department Dr. August James Troendle M.D. Chairman & Chief Executive Officer